Haemonetics Executive and Leadership Team

James D'Arecca, the Chief Financial Officer at Haemonetics, directs the company's financial strategy and operations. Overseeing all fiscal activities, D'Arecca ensures robust financial planning, accurate reporting, and effective capital allocation to support Haemonetics' global growth initiatives. This leadership role involves managing investor relations, optimizing financial performance, and maintaining strong relationships with financial institutions. By driving financial discipline, James D'Arecca directly contributes to the company's objective of reducing healthcare costs through its innovative medical products. The Chief Financial Officer's oversight extends to budgeting, forecasting, and risk management, safeguarding the company's assets and ensuring long-term financial stability. D'Arecca's strategic financial guidance underpins Haemonetics' mission to improve patient care worldwide.

Marcia Silvestro, the Group Chief Financial Officer at Haemonetics, manages the financial health and strategic fiscal direction for specific business units. Silvestro's responsibilities include overseeing financial planning, analysis, and reporting for key operational segments, ensuring alignment with the company's overall financial objectives. This role involves close collaboration with divisional leaders to drive profitability and manage financial risks. By providing targeted financial insights, Marcia Silvestro supports the effective deployment of resources for Haemonetics' innovative medical products. The Group Chief Financial Officer's expertise is crucial in navigating complex financial landscapes and optimizing financial performance across different market segments. Silvestro's leadership reinforces Haemonetics' dedication to reducing healthcare costs and improving patient outcomes.

Frankie Chan, the Executive Vice President & Chief Operating Officer at Haemonetics, orchestrates the company's global operational execution. Overseeing day-to-day business activities, Chan drives efficiency and effectiveness across all functional areas, ensuring seamless delivery of Haemonetics' medical products and solutions. This critical role involves managing supply chain logistics, manufacturing processes, and operational scaling to meet market demands. By optimizing operational workflows, Frankie Chan directly supports the company's commitment to improving patient care and reducing healthcare costs. The Chief Operating Officer's strategic focus ensures that Haemonetics' technology addresses key medical markets, including blood component collection and hospital transfusion services. Chan's leadership ensures operational excellence, reinforcing the company's legacy of innovation and customer support.

Keiko Hattori, the President, Haemonetics (Japan), leads the company's strategic initiatives and operational execution within the Japanese market. Hattori oversees all business functions in Japan, driving growth and ensuring the successful delivery of Haemonetics' innovative medical products and solutions to local customers. This leadership role involves developing market-specific strategies, managing regional sales and operations, and fostering strong customer relationships. By tailoring Haemonetics' offerings to the Japanese healthcare landscape, Keiko Hattori directly contributes to improving patient care and reducing healthcare costs in the region. The President's focus on local market dynamics ensures alignment with the company's global mission. Hattori's leadership strengthens Haemonetics' presence and impact in Japan, upholding the company's commitment to quality and integrity.

Gregory Olen, the Vice President, Chief Information Officer at Haemonetics, directs the company's information technology strategy and infrastructure. Olen oversees the development and implementation of robust IT systems that support Haemonetics' global operations, ensuring data security, system reliability, and technological innovation. This leadership position involves managing all aspects of the IT department, including cybersecurity, enterprise resource planning, and digital transformation initiatives. By leveraging technology, Gregory Olen enhances operational efficiency and supports the company's mission to improve patient care. The Chief Information Officer's strategic vision ensures that Haemonetics maintains a competitive edge through advanced technological solutions. Olen's expertise is vital for integrating IT effectively with business objectives, driving the company's commitment to quality and integrity.

Sandra Jesse, the Executive VP & Chief Legal Officer at Haemonetics, provides comprehensive legal counsel and oversees all legal affairs for the organization. Jesse directs the company's legal strategy, ensuring compliance with all applicable laws and regulations across its global operations. This pivotal role involves managing corporate governance, intellectual property, litigation, and regulatory matters related to Haemonetics' medical products and solutions. By safeguarding the company's legal interests, Sandra Jesse supports its commitment to integrity and quality. The Chief Legal Officer's expertise is essential in navigating the complex legal and regulatory environments of the healthcare industry. Jesse's leadership ensures that Haemonetics operates ethically and responsibly, reinforcing its dedication to improving patient care and reducing healthcare costs worldwide.